CMXTWENTY
Cmxtwenty is a Milwaukee based pharmaceutical company focused on the development of a unique lipid compound to be used as a non-narcotic treatment for pain. Established in November 2004, Cmxtwenty received its initial funding through an SBIR grant from the National Institute on Drug Abuse (NIDA). Since 2007, Cmxtwenty has been funded privately by a network of individual investors. Their lead product, CMX-020, is an analog of arachidonic acid, a common endogenous lipid and one of the most abundant lipids for cell signaling in the brain. Cmxtwenty maintains international patent filings on CMX-020 through 2029. Phase 1 clinical studies are currently ongoing.
CMXTWENTY
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2004-01-01
Address:
Milwaukee, Wisconsin, United States
Country:
United States
Website Url:
http://www.cytometix.com
Total Employee:
1+
Status:
Closed
Contact:
414-745-8000
Total Funding:
2.66 M USD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email
Current Employees Featured
Official Site Inspections
http://www.cytometix.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
